Evidence map›Paper›PMID 24140647›Full record

ArticleMicrobiology (Reading, England)2014

Functional analysis of SleC from Clostridium difficile: an essential lytic transglycosylase involved in spore germination.

Danielle Gutelius, Kirsten Hokeness, Susan M Logan, Christopher W Reid

Open access · greenAbstract read
In one paragraph

Article in Microbiology (Reading, England), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. Phenotypic analysis of variousApplied and environmental microbiology · 2025
    Article
  4. Article
  5. Phenotypic analysis of variousbioRxiv : the preprint server for biology · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. The small acid-soluble proteins ofbioRxiv : the preprint server for biology · 2024
    Article
  10. A dual-action antibiotic that killsProceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Danielle GuteliusDepartment of Science and Technology, Bryant University, Smithfield, RI 02917, USA.
Kirsten HokenessDepartment of Science and Technology, Bryant University, Smithfield, RI 02917, USA.
Susan M LoganNational Research Council - Human Health Therapeutics Portfolio, Ottawa, ON K1A 0R6, Canada.
Christopher W ReidDepartment of Science and Technology, Bryant University, Smithfield, RI 02917, USA.
Bryant University · USNational Research Council Canada · CA

Funding

Training CoreP20GM103430 · NIGMS · UNIVERSITY OF RHODE ISLAND · PI Bongsup P Cho · 2012 to 2026
$63.6M
NIGMS NIH HHS 8 P20 GM103430-12NIGMS NIH HHS P20 GM103430
6 · The paper itself

Abstract

Clostridium difficile is the most common cause of enteric disease and presents a major burden on healthcare systems globally due in part to the observed rapid rise in antibiotic resistance. The ability of C. difficile to form endospores is a key feature in the organism's pathogenesis and transmission, and contributes greatly to its resilient nature. Endospores are highly resistant to disinfection, allowing them to persist on hospital surfaces. In order for the organism to cause disease, the spores must germinate and revert to a vegetative form. While spore germination in Bacillus spp. is well understood, very little is known about this process in Clostridia. Here we report the characterization of SleC (CD0551) from C. difficile 630. Bioinformatic analysis of SleC indicated a multi-domained protein possessing a peptidoglycan-binding (PGB) domain, a SpoIID/LytB domain and an undefined N-terminal region. We have confirmed that SleC is an exo-acting lytic transglycosylase with the catalytic activity localized to the N-terminal region. Additionally, we have shown that both the N-terminal catalytic domain and the C-terminal PGB domain require muramyl-δ-lactam for substrate binding. As with carbohydrate-binding modules from cellulases and xylanases, the PGB domain may be responsible for increasing the processivity of SleC by concentrating the enzyme at the surface of the substrate.

Indexed as

Catalytic DomainClostridioides difficileComputational BiologyPeptidoglycanPeptidoglycan GlycosyltransferaseProtein BindingProtein Structure, TertiarySpores, BacterialPeptidoglycanPeptidoglycan Glycosyltransferase

Identifiers

PMID24140647
PMCPMC3917228
OpenAlexW2146333624

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.